Benzopyran compounds useful for treating inflammatory conditions
申请人:Carter Jeffery
公开号:US20050148777A1
公开(公告)日:2005-07-07
The subject invention concerns methods and compounds that have utility in the treatment of a condition associated with cyclooxygenase-2 mediated disorders. Compounds of particular interest are benzopyrans and their analogs defined by formula 1
Wherein Z, X, R
1
, R 2, R
3
, and R
4
are as described in the specification.
Benzopyran compounds for use in the treatment and prevention of inflammation related conditions
申请人:Carter Jeffery
公开号:US20050148627A1
公开(公告)日:2005-07-07
The subject invention concerns methods and compounds that have utility in the treatment of a condition associated with cyclooxygenase-2 mediated disorders. Compounds of particular interest are benzopyrans and their analogs defined by formula 1
Wherein Z, X, R
1
, R
2
, R
3
, and R
4
are as described in the specification.
This application relates to a substituted carboxamide compound of formula I, or a pharmaceutically acceptable salt thereof, as defined herein, a pharmaceutical composition thereof, and its use in treating pain.
This application relates to a substituted carboxamide compound of formula I, or a pharmaceutically acceptable salt thereof, as defined herein, a pharmaceutical composition thereof, and its use in treating pain.
Purification and Some Properties of a Hitherto-Unknown Enzyme Reducing the Carbon-Carbon Double Bond of alpha,beta-Unsaturated Carboxylate Anions
作者:Wilhelm TISCHER、Johann BADER、Helmut SIMON
DOI:10.1111/j.1432-1033.1979.tb13090.x
日期:1979.6
chromatography on DEAE-Sepharose CL-6B, hydroxylapatite and Sepharose CL-6B. The enzyme reduces different alpha,beta-unsaturated carboxylateanions such as (E)-2-butenoate, (E)-2-methyl-2-butenoate, (E)-cinnamate and probably many others in a NADH-dependent reaction to the saturated carboxylateanions. Fumarate, 3-phenyl-2-propinate, 2-enoyl-methyl and CoA esters proved not to be substrates for the purified